Form 4: Vivani Medical CEO Receives Stock Grant
Insider Transaction (Form 4)
Adam Mendelsohn, Chief Executive Officer and a Director of Vivani Medical, Inc., reported multiple transactions in common stock on July 28, 2026.
Summary
- Grant/award: acquired 200,000 Common Stock Option on July 28, 2026; holds 200,000 after (Direct).
- Grant/award: acquired 100,000 RSUs on July 28, 2026; holds 100,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Adam Mendelsohn — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Grant/award | Common Stock Option | 200,000 | — | — | 200,000 |
| 2026-07-28 | Grant/award | RSUs | 100,000 | — | — | 100,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Grant/award (200,000 shares) |
| 2026-07-28 | Grant/award (100,000 shares) |
Keywords
insider transaction, Form 4, VANI, Vivani Medical, Inc., neutral, Adam Mendelsohn
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.